Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies

Robert Stuver, Gunjan L. Shah, Neha Korde, Lindsey E. Roeker, Anthony R. Mato, Connie Lee Batlevi, David J. Chung, Sital Doddi, Lorenzo Falchi, Boglarka Gyurkocza, Audrey Hamilton, Ya-Hui Lin, Ann A. Jakubowski, Erel Joffe, Heather L. Landau, Richard J. Lin, Sham Mailankody, M. Lia Palomba, Jae H. Park, Miguel‐Angel Perales, Doris M. Ponce, Lakshmi V. Ramanathan, Gilles Salles, Michael Scordo, Susan K. Seo, Urvi A. Shah, Eytan M. Stein, David J. Straus, Saad Z. Usmani, James W. Young, Andrew D. Zelenetz, Ariela Noy, Santosha A. Vardhana